Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06896903

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

Led by Baylor Research Institute · Updated on 2026-05-05

50

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and related measurements in patients with angina but without significant coronary artery disease. This prospective, single-arm study involves patients undergoing coronary angiography for angina with non-obstructive coronary artery disease (ANOCA or INOCA). The goal is to understand changes in these coronary function measures before and after intracoronary nitroglycerin administration. Participants will undergo coronary reactivity testing (CRT) in the left anterior descending and right coronary arteries. First, measurements such as CFR, IMR, distal coronary to aortic pressure ratio (Pd/Pa), transit times, resting full-cycle ratio (RFR), fractional flow reserve (FFR), and resistive reserve ratio (RRR) will be taken without intracoronary nitrates. Then, a dose of 200-500 mcg of intracoronary nitroglycerin will be administered and the same measurements repeated to observe changes. During the study, approximately 50 patients will be monitored during their cardiac catheterization procedure. Data will be collected intraoperatively to compare coronary function variables before and after nitrate administration. Researchers will analyze primary outcomes focusing on CFR changes and secondary outcomes including IMR, Pd, Pa, RRR, and transit times. The study aims to provide detailed insight into coronary microcirculatory function in this patient population.

CONDITIONS

Brief Title

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 or older
  • Being evaluated for angina with non-obstructive coronary arteries (ANOCA) or ischemia with non-obstructive coronary artery disease (INOCA)
  • Clinical suspicion for angina
  • Able to comply with the study protocol
  • Provide written informed consent before participation
Not Eligible

You will not qualify if you...

  • Existing coronary artery disease
  • Previous percutaneous coronary interventions
  • Use of long-acting nitrate therapies within 48 hours
  • Use of PDE-5 inhibitors (e.g., sildenafil, tadalafil) within 48 hours
  • Any condition posing significant hazard as judged by the investigator
  • Children under 18 years, prisoners, pregnant people, or those unable to provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for consent and eligibility assessment

Treatment

Duration - Single day procedure

Participants undergo coronary reactivity testing first without intracoronary nitrates followed by administration of intracoronary nitrates and repeat testing to assess coronary function.

1 procedure visit (in-person) in the cardiac catheterization laboratory

Trial Site Locations

Total: 1 location

1

Baylor Scott & White The Heart Hospital - Plano

Plano, Texas, United States, 75093

Actively Recruiting

Loading map...

Research Team

B

Bonnie Ostergren

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review.

Nathaniel R Smilowitz, Megha Prasad, R Jay Widmer...

https://pubmed.ncbi.nlm.nih.gov/37704316

Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review.

Bruce A Samuels, Samit M Shah, R Jay Widmer...

https://pubmed.ncbi.nlm.nih.gov/37704315